PSA Screening Continues Despite USPSTF Guidance

Monday, October 10, 2016
Back in May of 2012, the United States Preventive Services Task Force (USPSTF) examined the use of PSA screening and concluded that the harms associated with the overtreatment of prostate cancer outweighed the benefits of its early detection. The USPSTF issued a “grade D” recommendation, which is a recommendation against the use of PSA-based screening for men of all ages.

Researchers at the University of Texas Southwestern Medical Center in Dallas used electronic medical records at their institution to analyze real-world data on PSA ordering and referral practices between January 2010 and July 2015. They reviewed 275,784 unique ambulatory visits for men and found 54,684 evaluable PSA orders. Primary care providers ordered 17,315 PSA tests and 858 urology referrals.

Over the 5-year study period, the number of PSA tests per ambulatory visit, the number of referrals per ambulatory visit, the age at the time of the urology referral, and the proportion of PSA tests performed outside the recommended age range did not significantly change.

The researchers concluded that despite the USPSTF recommendation in 2012 to avoid routine PSA testing, clinicians at the institution studied continued to use the PSA as a screening tool for prostate cancer. Although these results cannot be generalized to other healthcare institutions, their findings suggest that clinicians at other institutions also may be continuing to order this test.
Hutchinson R, Akhtar A, Haridas J, et al. Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening [published online ahead of print September 22, 2016]. Cancer.

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.